SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-20-000032
Filing Date
2020-04-15
Accepted
2020-04-15 16:27:03
Documents
1
Period of Report
2020-04-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158698240592447.html 4  
1 FORM 4 wf-form4_158698240592447.xml 4 7192
  Complete submission text file 0001439222-20-000032.txt   8635
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Biller Jonathan (Reporting) CIK: 0001744749 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 20793987